Variant report
Variant | esv3335265 |
---|---|
Chromosome Location | chr2:234709697-234710140 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000241635 | chromatin interactions |
ENSG00000241119 | chromatin interactions |
ENSG00000244474 | chromatin interactions |
ENSG00000244122 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75945530 | chr2:234709705-234709706 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs140067007 | chr2:234709725-234709726 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs57768423 | chr2:234709750-234709751 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs116306868 | chr2:234709760-234709761 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs545360303 | chr2:234709787-234709788 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs150381242 | chr2:234709821-234709822 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs11678741 | chr2:234709831-234709832 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs537731166 | chr2:234709857-234709858 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs552538663 | chr2:234709895-234709896 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs557244624 | chr2:234709903-234709904 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs563095935 | chr2:234709983-234709984 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs184301104 | chr2:234709997-234709998 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs574065871 | chr2:234710024-234710025 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs188743807 | chr2:234710034-234710035 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs552994385 | chr2:234710061-234710062 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs573277135 | chr2:234710070-234710071 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs181515688 | chr2:234710113-234710114 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs564283684 | chr2:234710114-234710115 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 22429812 | CNVD |
Bladder cancer | 21909424 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mental retardation | 20152051 | CNVD |
Cancer | 21183584 | CNVD |
Albright''s disease | 22277900 | CNVD |
Brachydactyly-Mental Retardation Syndrome | 22470819 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Autism | 18414403 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:234708000-234712600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr2:234709600-234710600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr2:234709600-234710800 | Enhancers | HMEC | breast |
4 | chr2:234709800-234710400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr2:234709800-234710400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr2:234709800-234710400 | Enhancers | A549 | lung |
7 | chr2:234709800-234710400 | Enhancers | NHEK | skin |
8 | chr2:234709800-234710600 | Enhancers | GM12878-XiMat | blood |
9 | chr2:234710000-234710400 | Enhancers | NH-A | brain |